Review Article
An Increasing Prominent Disease of Klebsiella pneumoniae Liver Abscess: Etiology, Diagnosis, and Treatment
Table 4
Antibiotic treatment in patients with Klebsiella pneumoniae liver abscess and Streptococcus milleri liver abscess.
| | | KLA | Streptococcus milleri | | | Hong Kong (38) () | Singapore (4) () | Taiwan (62) () | Turkey (61) () | Hong Kong (38) () | | | Duration (days) | Efficiency | Duration (days) | Efficiency | Duration (days) | Efficiency | Duration (days) | Efficiency | Duration (days) | Efficiency |
| | Extended-spectrum penicillin* |
21.7 | 48 (34.3%) | — | — | — | — | — | 4 (4.7%) |
15.4 | 11 (52.4%) | | First- and second-generation cephalospori |
21.7 | 30 (21.4%) | | 24 (22.0%) | — | 104 (94.5%) | — | — |
15.4 | 4 (19%) | | Third- and fourth-generation cephalosporins▲ |
21.7 | 50 (35.7%) | | 71 (65.1%) | — | 4 (3.6%) | — | 5 (5.9%) |
15.4 | 3 (14.3%) | |
Carbapenems∧ | — | — | | 13 (11.9%) | — | — | — | 42 (49.4%) | — | — | | Aminoglycosides# | — | — | — | 1 (0.9%) | — | 104 (94.5%) | — | 2 (2.4%) | — | — | |
Quinolone** | — | — | — | — | — | — | — | 11 (12.9%) | — | — |
|
|
Piperacillin-tazobactam, ticarcillin-clavulanate; cefazolin; ceftriaxone, cefepime; ertapenem, meropenem; amikacin; ciprofloxacin.
|
